"A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations (OFF Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations (OFF Episodes)"

PHASE3CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

August 11, 2021

Study Completion Date

August 11, 2021

Conditions
Motor OFF Episodes Associated With Parkinson's Disease
Interventions
DRUG

APL-130277

APL-130277: Part A- determine the dose; Part B- 28-day repeat dosing at the dose determined in Part A

DRUG

subcutaneous apomorphine

subcutaneous apomorphine Part A- determine the dose; Part B- 28-day repeat dosing at the dose determined in Part A

Trial Locations (31)

10117

Charite-University Medicine Berlin, Department of Neurology, Campus charite Mitte, Berlin

13088

St. Joseph Krankenhaus Berlin - Weissensee, Abteilung fur Neurologie, Berlin

14547

Klinken Beelitz GmbH Neurologisches Fachkrankenhaus fur Bewegungsstorungen/Parkinson, Beelitz-Heilstätten

20089

Istituto Clinico Humanitas, Dipartmento di Neurologia 1, Rozzano

28006

Hospital Universitario de la Princesa, Madrid

28938

CINAC, Hospital Universitario HB Pueta del Sur, Móstoles

30029

CHU Caremeau, Service de Neurologie, Nîmes

31059

Centre d'Investigation Clinique, CIC 43, CHU Purpan, Hopital Pierre-Paul Riquet, place du Dr. Baylac, Hall D, 2 eme etage -TSA, Toulouse

44791

St. Josef Hospital, Klnikum der Ruhr-Universitat-Bochum, Neurologische Klinik, Bochum

80138

"A.O.U. Universita degli Studi della Campania Luigi Vanvitelli Dipartamento di Scienze Mediche e Chirurgiche Avanzate", Napoli

80331

Curiositas ad sanum GmbH, Munich

81675

Klinikum rechts der Isar der Technischen Universitat Munchen, München

83527

Klinik Haag i.OB, Haag in Oberbayern

84131

AOU San Giovanni di Dio e Ruggid'Aragona-CEMAND, Salerno

A-6020

Medical University Innsbruck, Neurolgy Dept, Innsbruck

A-1160

Wilhelminenspital, Department of Neurology, Vienna

01307

Universitatsklinikum Carol Gustav Carus an der TU dDresden, Klinik umd Poliklinik fur Neurologie, Dresden

D-89081

Universitaets-und Rehabillitatinskliniken Ulm, Ulm

03043

San Raffaele Cassino, Cassino

Unknown

"University Hospital Policlinico-Vittorio Emanuele, Department G.F. Ingrassia, Section of Neurosciences", Catania

Hospital Universitario de Cruces, Neurology, Barakaldo

00163

IRCCS San Raffaele Pisana-Clinical Trial Center, Rome

08036

Hospital Clinic de Barcelona, Barcelona

08041

Hospital de la Santa Creu i Sant Pau c/Mas de Casanovas 90, Barcelona

09006

Hospital Universitario de Burgos, Burgos

08195

Hospital General de Catalunya, Sant Cugat del Vallès

SE5 9RS

King's College Hospital NHS Foundation Trust, London

W6 8RF

10W, Imperial Memory/PD Research Unit, Imperial College Healthcare NHS Trust, London

Bl9 7TD

NHS Forth Valley, Pennine Actue NHS Trust, Fairfield General Hospital, Manchester

NG7 2UH

Academic Neuroscience Department, C Floor, South Block, Nottingham University Hospitals NHS Trust Queens Medical Centre, Nottingham

PL6 8DH

University Hospitals Plymouth NHS Trust-Derriford Hospital-The Lind Research Center, Level 5, Terence Lewis Building, Plymouth

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT03391882 - "A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations (OFF Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations (OFF Episodes)" | Biotech Hunter | Biotech Hunter